Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
TWITI Investments is a private investment company founded over 15 years ago, specifically in 2011. Headquartered in Nicosia, Cyprus, the firm operates primarily from Poland. It is recognized as the largest biotech and medtech private investment fund in Central and Eastern Europe (CEE). The firm specializes in financing and supporting innovative startup companies in the biotech and medtech sectors, emphasizing breakthrough technologies that can significantly improve therapeutic approaches and patient outcomes.
As of now, TWITI Investments manages a portfolio of 9 notable companies and has a team of 5 members, including 2 partners and 1 venture partner. The firm has established itself as a key player in the CEE market, particularly after becoming a partner fund of Poland's NCBR Investment Fund (NIF) in October 2024, which allows for co-investment with national capital. This partnership enhances TWITI's ability to support startups in the region.
TWITI Investments primarily targets biotech and medtech startups, focusing on teams of scientists and managers with an entrepreneurial spirit. The firm invests in projects that require time to achieve specific milestones, emphasizing breakthrough technologies that can significantly change current therapeutic approaches. Their investment strategy includes seed and Series A stages, with a follow-on capability for successful ventures.
The sectors of interest include novel therapeutics, medical devices, diagnostic platforms, and digital health applications that address unmet medical needs. Geographically, TWITI focuses on Central and Eastern Europe, while also targeting market entry into the US and Western Europe for its portfolio companies. The firm employs a 'smart money' approach, combining capital with strategic counseling and access to a robust network of pharmaceutical companies, research institutions, regulatory experts, and follow-on investors.
TWITI Investments has a diverse portfolio of 9 notable companies, each contributing to advancements in the biotech and medtech sectors:
This portfolio reflects TWITI's commitment to supporting innovative solutions that can transform healthcare and improve patient outcomes.
Robert Aleksandrowicz, MD, MBA — Co-founder of TWITI Investments, Robert is a physician-entrepreneur with a strong background in the life sciences. He has founded several companies, including Genexo, Mabion, Lipid Systems, Captor Therapeutics, Fluid Screen, Urteste, and Human Biome Institute. His experience as an operator-turned-investor provides deep domain credibility.
In addition to Robert, TWITI Investments has a team of 5 members, including 2 partners and 1 venture partner, all based in Poland. This small, focused team allows for high conviction and a concentrated portfolio model.
To pitch to TWITI Investments, founders should reach out through their website. It is advisable to include a comprehensive deck that outlines the startup's vision, team, technology, and market potential. While specific application forms are not disclosed, a clear and concise presentation will enhance the chances of engagement. Response times may vary, so founders should be prepared for a potential wait after submission.
In October 2024, TWITI Investments became a partner fund of Poland's NCBR Investment Fund (NIF), enabling co-investment with national capital. This partnership marks a significant milestone for the firm, confirming its active status and institutional validation in the CEE market.
TWITI has been actively involved in financing and supporting innovative startups in the biotech and medtech sectors, with a portfolio that includes 9 notable companies. Their recent focus includes providing counseling and networking opportunities to help these companies scale globally.
What are TWITI Investments' investment criteria?
TWITI Investments primarily invests in biotech and medtech startups, focusing on teams of scientists and managers with an entrepreneurial spirit. They look for projects that require time to achieve specific milestones and emphasize breakthrough technologies that can significantly change current therapeutic approaches.
How can startups apply or pitch to TWITI Investments?
Startups interested in pitching to TWITI Investments should reach out through their website for inquiries or project submissions. Specific application forms or portals are not publicly disclosed.
What makes TWITI Investments different from other venture capital firms?
TWITI Investments is recognized as the largest biotech and medtech private investment fund in Central and Eastern Europe. Their 'smart money' approach combines capital with strategic counseling and access to a robust network of pharmaceutical companies, research institutions, and regulatory experts.
What is the geographic scope of TWITI Investments?
TWITI Investments primarily focuses on Central and Eastern Europe, but they also target market entry into the US and Western Europe for their portfolio companies.
What is the typical fund size or check size for investments?
The fund size and specific check sizes are not publicly disclosed, but TWITI Investments is known for its active involvement in seed and Series A funding rounds.
What kind of post-investment involvement does TWITI Investments have?
TWITI Investments provides ongoing support to its portfolio companies through strategic counseling and access to their extensive network, enhancing the growth potential of their investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.